UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
12/2015, Volume 49, Issue 12, 7
sympatholytics | critical care | withdrawal | alcohol intoxication | substance abuse | sedatives | central nervous system | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Alcohol Withdrawal Delirium - drug therapy | Dexmedetomidine - therapeutic use | Intensive Care Units | Ethanol - adverse effects | Humans | Hypertension - prevention & control | Substance Withdrawal Syndrome - drug therapy | Hypnotics and Sedatives - therapeutic use | Tachycardia - prevention & control | Respiration, Artificial | Index Medicus
Book Review
The American journal of psychiatry, ISSN 0002-953X, 11/2004, Volume 161, Issue 11, pp. 1967 - 1977
Life Sciences & Biomedicine | Psychiatry | Science & Technology | Drug addiction | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Addictive behaviors | Biological and medical sciences | Medical sciences | Severity of Illness Index | Marijuana Abuse - prevention & control | Reproducibility of Results | Prevalence | Substance Withdrawal Syndrome - prevention & control | Humans | Hospitalization | Ambulatory Care | Incidence | Animals | Marijuana Abuse - diagnosis | Substance Withdrawal Syndrome - epidemiology | Dronabinol - therapeutic use | Substance Withdrawal Syndrome - diagnosis | Marijuana Abuse - epidemiology | Marijuana | Research | Validity | Substance abuse treatment | Patients | Medical treatment | Index Medicus | Abridged Index Medicus
Journal Article
Obstetrics and gynecology clinics of North America, ISSN 0889-8545, 2014, Volume 41, Issue 2, pp. 317 - 334
Neonatal opioid withdrawal | Methadone | Buprenorphine | Perinatal substance abuse | Neonatal abstinence syndrome | Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | United States | Humans | Pregnancy Complications | Risk Factors | Breast Feeding | Methadone - therapeutic use | Neonatal Abstinence Syndrome - epidemiology | Analgesics, Opioid - therapeutic use | Male | Pregnancy | Buprenorphine - therapeutic use | Substance-Related Disorders - prevention & control | Female | Neonatal Abstinence Syndrome - drug therapy | Opiate Substitution Treatment | Substance-Related Disorders - drug therapy | Infant, Newborn | Pregnancy Outcome
Journal Article
4.
Full Text
Gamma‐hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses
Cochrane library, ISSN 1469-493X, 2010, Volume 2011, Issue 4, pp. CD006266 - CD006266
Tobacco, drugs & alcohol | Alcohol abuse and dependence | Ethanol | Sodium Oxybate | Pharmacological interventions | Alcoholism | Alcohol | Secondary Prevention | Substance Withdrawal Syndrome | Medicine General & Introductory Medical Sciences | Randomized Controlled Trials as Topic | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Sodium Oxybate - adverse effects | Ethanol - adverse effects | Humans | Substance Withdrawal Syndrome - drug therapy | Alcoholism - complications | Sodium Oxybate - therapeutic use | Index Medicus
Journal Article
Regional anesthesia and pain medicine, ISSN 1098-7339, 11/2009, Volume 34, Issue 6, pp. 600 - 602
Life Sciences & Biomedicine | Anesthesiology | Science & Technology | Device Removal | Muscle Relaxants, Central - administration & dosage | Spinal Cord Injuries - drug therapy | Substance Withdrawal Syndrome - etiology | Spinal Cord Injuries - complications | Substance Withdrawal Syndrome - prevention & control | Humans | Middle Aged | Male | Baclofen - adverse effects | Anti-Bacterial Agents - therapeutic use | Catheters, Indwelling - adverse effects | Infusion Pumps, Implantable | Drug Administration Schedule | Administration, Oral | Baclofen - administration & dosage | Infusions, Parenteral | Treatment Outcome | Accidents, Traffic | Paraplegia - etiology | Clonidine - analogs & derivatives | Paraplegia - drug therapy | Catheter-Related Infections - microbiology | Muscle Relaxants, Central - adverse effects | Clonidine - administration & dosage | Index Medicus
Journal Article
Alcohol and alcoholism (Oxford), ISSN 0735-0414, 06/2020, Volume 55, Issue 4, pp. 350 - 353
Life Sciences & Biomedicine | Substance Abuse | Science & Technology | Coronavirus Infections - prevention & control | Substance Withdrawal Syndrome - etiology | Humans | Pandemics - prevention & control | Hospitalization - statistics & numerical data | India - epidemiology | Male | Incidence | COVID-19 | SARS-CoV-2 | Coronavirus Infections - epidemiology | Pneumonia, Viral - epidemiology | Pneumonia, Viral - prevention & control | Hospitalization - trends | Substance Withdrawal Syndrome - epidemiology | Betacoronavirus | Adult | Social Isolation | Index Medicus
Journal Article
American journal of critical care, ISSN 1062-3264, 2013, Volume 22, Issue 5, pp. 398 - 406
Nursing | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Length of Stay | Intensive Care Units | Prospective Studies | Substance Withdrawal Syndrome - prevention & control | Humans | Middle Aged | Substance Withdrawal Syndrome - drug therapy | Male | Ethanol - therapeutic use | Hypnotics and Sedatives - therapeutic use | Alcoholism - diagnosis | Lorazepam - therapeutic use | Pilot Projects | Acute Coronary Syndrome - complications | Central Nervous System Depressants - therapeutic use | Adult | Female | Alcoholism - complications | Drug Therapy, Combination | Index Medicus | patient safety | alcohol withdrawal syndrome | lorazepam | ethanol | acute myocardial infarction | CAGE questionnaire | randomized controlled trial
Journal Article
Expert opinion on pharmacotherapy, ISSN 1465-6566, 02/2014, Volume 15, Issue 2, pp. 245 - 257
GHB | alcoholism | SMO | gamma-hydroxybutyric acid | Gamma-hydroxybutyric acid | Alcoholism | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Toxicology | Psychology. Psychoanalysis. Psychiatry | Adult and adolescent clinical studies | Psychopathology. Psychiatry | Addictive behaviors | Biological and medical sciences | Medical sciences | Alcoholism and acute alcohol poisoning | Alcohol Drinking - prevention & control | Humans | Substance Withdrawal Syndrome - drug therapy | Treatment Outcome | Drug Approval | Secondary Prevention | Alcoholism - rehabilitation | Temperance | Sodium Oxybate - adverse effects | Animals | Alcoholism - drug therapy | Sodium Oxybate - therapeutic use | Substance Withdrawal Syndrome - physiopathology | Index Medicus
Journal Article
Journal of clinical psychopharmacology, ISSN 0271-0749, 02/2014, Volume 34, Issue 1, pp. 153 - 156
Alcohol withdrawal delirium | GABA-B receptors | Substance withdrawal syndrome | Adverse drug event | GABA-A receptors | Baclofen | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Confusion - chemically induced | Predictive Value of Tests | Off-Label Use | Substance Withdrawal Syndrome - etiology | Humans | Middle Aged | Substance Withdrawal Syndrome - drug therapy | Male | GABA-B Receptor Agonists - adverse effects | Alcoholism - diagnosis | Baclofen - adverse effects | Adult | Alcohol Withdrawal Delirium - diagnosis | Alcohol Withdrawal Delirium - psychology | Alcoholism - psychology | Alcohol Drinking - prevention & control | Diagnosis, Differential | Risk Factors | Alcohol Abstinence | Alcohol Withdrawal Delirium - drug therapy | Alcohol Withdrawal Delirium - etiology | Alcoholism - therapy | Substance Withdrawal Syndrome - psychology | Substance Withdrawal Syndrome - diagnosis | Delirium - chemically induced | Index Medicus
Journal Article
Psychopharmacology, ISSN 0033-3158, 1/2017, Volume 234, Issue 2, pp. 223 - 234
Cues | Neurosciences | Relapse | Biomedicine | Addiction | Yohimbine | Withdrawal | Pioglitazone | Priming | Pharmacology/Toxicology | Psychiatry | Heroin | Pharmacology & Pharmacy | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Recurrence | Rats, Wistar | Substance Withdrawal Syndrome - prevention & control | Conditioning, Operant - physiology | Male | Behavior, Addictive - prevention & control | Self Administration | Thiazolidinediones - therapeutic use | Conditioning, Operant - drug effects | Opioid-Related Disorders - prevention & control | Heroin - administration & dosage | Behavior, Addictive - physiopathology | Opioid-Related Disorders - psychology | Rodentia | Rats | Narcotics - administration & dosage | Animals | Analgesics, Opioid - administration & dosage | Mice | Behavior, Addictive - psychology | Opioid-Related Disorders - physiopathology | Substance Withdrawal Syndrome - physiopathology | Morphine - administration & dosage | Substance Withdrawal Syndrome - psychology | Prevention | Drug abuse | Dosage and administration | Opioids | Addictions | Rodents | Psychopharmacology | Index Medicus
Journal Article
Journal of consulting and clinical psychology, ISSN 0022-006X, 6/2010, Volume 78, Issue 3, pp. 362 - 374
substance use | craving | depression | negative affect | mindfulness based relapse prevention | Psychology, Clinical | Psychology | Social Sciences | Intervention | Therapy | Behavior Modification | Prediction | Cognitive Restructuring | Metacognition | Control Groups | Substance Abuse | Depression (Psychology) | Prevention | Outcomes of Treatment | Alcohol Abuse | Rehabilitation | Symptoms (Individual Disorders) | Beck Depression Inventory | Relaxation. Biofeedback. Hypnosis. Selfregulation. Meditation | Psychology. Psychoanalysis. Psychiatry | Psychopathology. Psychiatry | Biological and medical sciences |